0001493152-20-023590.txt : 20201215 0001493152-20-023590.hdr.sgml : 20201215 20201215062011 ACCESSION NUMBER: 0001493152-20-023590 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201211 FILED AS OF DATE: 20201215 DATE AS OF CHANGE: 20201215 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Parker Albert P CENTRAL INDEX KEY: 0001750079 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37648 FILM NUMBER: 201388152 MAIL ADDRESS: STREET 1: C/O ONCOCYTE CORPORATION STREET 2: 1010 ATLANTIC AVENUE, SUITE 102 CITY: ALAMEDA STATE: CA ZIP: 94501 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OncoCyte Corp CENTRAL INDEX KEY: 0001642380 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 271041563 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 15 CUSHING CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: 949-409-7600 MAIL ADDRESS: STREET 1: 15 CUSHING CITY: IRVINE STATE: CA ZIP: 92618 FORMER COMPANY: FORMER CONFORMED NAME: Oncocyte Corp DATE OF NAME CHANGE: 20200205 FORMER COMPANY: FORMER CONFORMED NAME: OncoCyte Corp DATE OF NAME CHANGE: 20150513 4 1 ownership.xml X0306 4 2020-12-11 0 0001642380 OncoCyte Corp OCX 0001750079 Parker Albert P C/O ONCOCYTE CORPORATION 15 CUSHING IRVINE CA 92618 0 1 0 0 COO Common Stock 2020-12-11 4 A 0 5586 A 10586 D The shares of the Issuer's common stock were issued to the Reporting Person for the repayment of deferred compensation in lieu of cash at a price of $2.07 per share. /s/ Albert P. Parker 2020-12-15